首页 > 市场调查报告书 > 医疗设备

生物材料

神经修復与再生市场规模、份额及成长分析（按产品、流程及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897858

神经修復与再生市场规模、份额及成长分析（按产品、流程及地区划分）－2026-2033年产业预测

Nerve Repair and Regeneration Market Size, Share, and Growth Analysis, By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Surgery (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球神经修復和再生市场规模预计在 2024 年达到 95.5 亿美元，从 2025 年的 107.2 亿美元增长到 2033 年的 271.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 12.3%。

由于神经系统疾病的日益普遍，全球神经修復和再生市场正经历显着增长。包括帕金森氏症和阿兹海默症在内的神经退化性疾病的增加，推动了对以神经细胞再生和修復为重点的先进治疗方法的需求。外科技术、生物製药和医疗设备的创新显着改善了神经系统疾病的治疗效果，进一步推动了市场发展。儘管医疗领域的动盪影响了慢性病管理，但中枢神经系统治疗（例如神经移植、干细胞疗法和神经保护剂）的持续进步，使该领域的未来充满希望。神经修復的应用范围从退化性疾病扩展到创伤性损伤，这代表着一个充满活力的市场，在研发和创新的推动下，该市场有望持续成长。

全球神经修復与再生市场驱动因素

全球神经修復和再生市场主要受多发性硬化症、帕金森氏症、阿兹海默症和脊髓损伤等神经系统疾病发病率上升的驱动。随着人口老化和生活方式相关因素加剧这些疾病的发生，对有效治疗方法的需求持续增长。在医疗体系发达的地区，这趋势特别显着，创新型神经修復疗法在这些地区正日益普及。人们对神经系统疾病有效管理的认识不断提高，以及对有效管理的需求不断增长，正在推动市场扩张，并反映出人们致力于改善神经系统疾病患者预后的广泛努力。

全球神经修復与再生市场阻碍因素

全球神经修復和再生市场面临的主要挑战之一是现代神经修復疗法（包括干细胞疗法和再生医学）的高成本。这些先进治疗方法通常需要在技术和研发方面投入大量资金，使得相当一部分患者，尤其是在中低收入国家，难以负担。此外，高昂的治疗费用阻碍了这些疗法的广泛应用，并成为医疗预算有限地区市场成长的障碍。因此，资金仍是限制这些创新医疗解决方案普及和应用的重要阻碍因素。

全球神经修復与再生市场趋势

在提升病患体验需求的驱动下，微创技术的应用已成为全球神经修復与再生市场的一大趋势。腹腔镜、内视镜和机器人辅助手术等微创手术因其疼痛减轻、恢復更快、併发症率更低等优势而日益受到青睐。这种转变不仅改善了治疗效果，也简化了操作流程，为医疗保健行业的更广泛接受和应用铺平了道路。随着这些技术的不断发展，预计将显着推动市场成长，并重塑神经损伤的治疗模式。

北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Medtronic（US）
Boston Scientific Corporation（US）
Abbott Laboratories（US）
Stryker Corporation（US）
AxoGen, Inc.（US）
Integra LifeSciences Holdings Corporation（US）
Baxter International Inc.（US）
Nevro Corp（US）
LivaNova PLC（UK）
Cyberonics Inc.（US）
Orthofix Medical Inc.（US）
Polyganics（Netherlands）
Nuvectra Corporation（US）
Polyganics BV（Netherlands）
BioTime Inc.（US）
Collagen Matrix, Inc.（US）
Synovis Micro Companies Alliance, Inc.（US）
StimGuard LLC（US）
Nexeon MedSystems Inc.（US）
Checkpoint Surgical, Inc.（US）

简介目录

Product Code: SQMIG35I2162

Global Nerve Repair and Regeneration Market size was valued at USD 9.55 Billion in 2024 and is poised to grow from USD 10.72 Billion in 2025 to USD 27.13 Billion by 2033, growing at a CAGR of 12.3% during the forecast period (2026-2033).

The global nerve repair and regeneration market is experiencing significant growth driven by the rising prevalence of neurological disorders. Conditions such as Parkinson's, Alzheimer's, and other neurodegenerative diseases have heightened the demand for advanced therapies focused on neuron regeneration and repair. Innovations in surgical methodologies, biologics, and medical devices have markedly enhanced treatment outcomes for neurological conditions, further propelling market advancement. Although healthcare disruptions impacted chronic disease management, the future of this sector looks promising with ongoing advancements in central nervous system therapies, including nerve grafts, stem cell interventions, and neuroprotective agents. The expansion of applications for nerve repair, from degenerative diseases to traumatic injuries, is indicative of a robust market poised for continued growth fueled by research and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair and Regeneration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair and Regeneration Market Segments Analysis

Global Nerve Repair and Regeneration Market is segmented by Product, Surgery and region. Based on Product, the market is segmented into Biomaterials and Neurostimulation and Neuromodulation Devices. Based on Surgery, the market is segmented into Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and Neurostimulation and Neuromodulation Surgeries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is significantly fueled by the rising incidence of neurological disorders such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and spinal cord injuries. As populations age and lifestyle-related factors contribute to an increase in these conditions, the demand for effective treatment options continues to escalate. This trend is particularly notable in regions with advanced healthcare systems, where innovative nerve repair therapies are gaining traction. The growing awareness and need for effective management of neurological issues drive the expansion of the market, reflecting a broader commitment to enhancing patient outcomes in nerve health.

Restraints in the Global Nerve Repair and Regeneration Market

A major challenge facing the Global Nerve Repair and Regeneration market is the high cost associated with contemporary nerve repair therapies, including stem cell treatments and regenerative medicine. These advanced therapies often require substantial financial investment in both technology and research, rendering them inaccessible for a significant portion of the patient population, particularly in low- and middle-income countries. Additionally, the elevated treatment expenses can inhibit widespread adoption, posing a barrier to market growth in regions with limited healthcare budgets. Consequently, the financial aspect remains a significant restraint, limiting the potential reach and implementation of these innovative medical solutions.

Market Trends of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is witnessing a significant trend towards the adoption of less invasive techniques, driven by the demand for improved patient experiences. Minimally invasive procedures, including laparoscopic surgery, endoscopy, and robotic-assisted operations, are gaining traction due to their benefits of reduced pain, shorter recovery times, and lower complication rates. This shift not only enhances therapeutic outcomes but also streamlines operational processes, paving the way for broader acceptance and implementation across the healthcare sector. As these technologies continue to evolve, they are expected to significantly enhance market growth and reshape treatment paradigms for nerve injuries.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Macroeconomic Indicators
Top Investment Analysis

Global Nerve Repair and Regeneration Market by Product Type

Market Overview
Neurostimulation and Neuromodulation Devices
Biomaterials

Global Nerve Repair and Regeneration Market by Application

Market Overview
Peripheral Nerve Injury
Epilepsy
Parkinson's Disease
Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

Market Overview
North America
- USA
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AxoGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTime Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synovis Micro Companies Alliance, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StimGuard LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Checkpoint Surgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments